In a recent discussion, Gautam Jha, MD, medical director at M Health Fairview Masonic Cancer Clinic, and Emmanuel Antonarakis, MD, associate director of Translational Research at Masonic Cancer Center, highlighted the benefits of collaboration between community and academic oncologists.
They emphasized the need to address logistical challenges and dispel historical misconceptions in order to promote a more inclusive and collaborative approach to cancer research and patient care. Community practitioners, in particular, face hurdles such as awareness of all available clinical trials and treating a diverse range of cancer patients, unlike university oncologists who specialize in specific cancer types.
Antonarakis stressed the evolving dynamic between academic and community oncologists, advocating for mutual respect and collaboration over rivalry. He encouraged community oncologists to view their academic counterparts as valuable resources for discussing complex cases instead of solely referring patients for clinical trials.
Both physicians underscored the importance of patient-centered care and collaboration to improve clinical trial enrollment. Jha highlighted the logistical challenges that community oncologists face, calling for increased support and resources to facilitate their participation in trials. Antonarakis emphasized the need for open communication and mutual respect to overcome barriers to trial enrollment and foster a more inclusive approach to cancer research and care.
By dispelling misconceptions and fostering a collaborative spirit between academic and community oncologists, the oncology community can work towards enhancing patient care and advancing cancer research in a more cohesive manner.
